Compare · LIVN vs SEAS
LIVN vs SEAS
Side-by-side comparison of LivaNova PLC (LIVN) and SeaWorld Entertainment Inc. (SEAS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LIVN and SEAS operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- SEAS is the larger of the two at $4.50B, about 1.3x LIVN ($3.51B).
- LIVN has hit the wire 1 time in the past 4 weeks while SEAS has been quiet.
- LIVN has more recent analyst coverage (20 ratings vs 16 for SEAS).
- Company
- LivaNova PLC
- SeaWorld Entertainment Inc.
- Price
- $64.18-1.47%
- $50.34+2.56%
- Market cap
- $3.51B
- $4.50B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NYSE
- IPO
- 2013
- News (4w)
- 1
- 0
- Recent ratings
- 20
- 16
LivaNova PLC
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
SeaWorld Entertainment Inc.
SeaWorld Entertainment, Inc., together with its subsidiaries, operates as a theme park and entertainment company in the United States. The company operates SeaWorld theme parks in Orlando, Florida; San Antonio, Texas; and San Diego, California, as well as Busch Gardens theme parks in Tampa, Florida, and Williamsburg, Virginia. It also operates water park attractions in Orlando, Florida; San Antonio, Texas; Chula Vista, California; Tampa, Florida; and Williamsburg, Virginia. In addition, the company operates a reservations-only theme park in Orlando, Florida and a seasonal park in Langhorne, Pennsylvania. It operates a portfolio of twelve theme parks under the SeaWorld, Busch Gardens, Aquatica, Discovery Cove, Water Country USA, Adventure Island, and Sesame Place brands. The company was formerly known as SW Holdco, Inc. and changed its name to SeaWorld Entertainment, Inc. in December 2012. SeaWorld Entertainment, Inc. was founded in 1959 and is headquartered in Orlando, Florida.
Latest LIVN
- Annals of Internal Medicine Publishes 12-Month Results from LivaNova's OSPREY Clinical Study for Obstructive Sleep Apnea
- SEC Form 4 filed by Tezel Ahmet
- SEC Form 4 filed by Poletti Franco
- SEC Form 4 filed by Makatsaria Vladimir
- SEC Form 4 filed by Shvartsburg Alex
- SEC Form 4 filed by Bolton Stephanie
- SEC Form 4 filed by Kozmina Natalia
- MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
- LivaNova to Announce First-Quarter 2026 Results
- LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
Latest SEAS
- SeaWorld San Antonio Reveals Plans for the ALL-NEW Rescue Jr. Hub, a Kid-Friendly World of Discovery Packed with Interactive Play, Immersive Attractions and a One-Of-A-Kind Water Elements - Opening Spring 2025
- Get Ready for Jaw-Dropping Adventures as SeaWorld's Ultimate Shark Experience Returns for 2024
- SeaWorld and Coca-Cola Say Cheers to 60 Years with New Celebration Sundays Featuring Exclusive Merchandise Giveaways for Pass Members and Complimentary Beverage Sampling for All Guests
- SeaWorld Unveils 60th Anniversary Celebration Plans for 2024
- SeaWorld Entertainment Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form SC 13G filed by SeaWorld Entertainment Inc.
- SEAWORLD ENTERTAINMENT, INC. ANNOUNCES FOURTH QUARTER AND FISCAL 2023 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION
- Splash Beverage Partners With Sea World Parks & Entertainment; Pulpoloco Sangria Available At Venues
- SeaWorld Launches 60th Anniversary Celebrations and Unveils "There's So Much More to Sea"
- SeaWorld Entertainment Changes Corporate Name To United Parks & Resorts